Talaat Moustafa Group has entered a strategic partnership with Alameda Group, a leading international hospital operator, to develop and manage high-quality medical and healthcare services in its projects.

Italy’s San Donato Hospital Group plans to invest $100 million in the first phase of a new hospital project in Egypt, with further expansion across several governorates.

The Arab Company for Pharmaceutical Raw Materials (Arab API) and the General Authority for the Suez Canal Economic Zone (SCZone), represented by the Economic Zone Investment Company Egypt's first multi-purpose factory for raw pharmaceutical materials.

The Egyptian medicine city Gypto Pharma is in advanced negotiations to finalize agreements with two international firms in the first half (H1) of 2025.

Egypt has officially launched the Egyptian Vaccine Manufacturers Alliance (EVMA), an initiative that aims to localize vaccine production and expand exports across Africa.

Egypt is setting a comprehensive national strategy to localize vaccine production, aiming to reduce reliance on imports, strengthen local manufacturing, and position Egypt as a key regional exporter.

Egypt is targeting to increase its medical exports by approximately 15% in 2025 to reach $1.5 billion, from the projected $1.3 billion by the end of 2024.

The Egyptian cabinet approved a draft law aimed at regulating medical liability and enhancing patient protection.

M42, an Abu Dhabi-based AI-driven healthcare firm, is considering new expansion opportunities in Egypt as part of its strategy to extend its advanced healthcare services globally.

The Suez Canal Economic Zone (SCZone) is set to establish a dedicated pharmaceutical industrial zone covering 4 million square meters (sqm), SCZone's Head Waleid Gamal El-Dien announced during his participation in the fourth edition of the PharmaRegAfriSummit.

Egyptian pharmaceutical companies need $1 billion in the fourth quarter (Q4) of 2024 to import essential raw materials and production inputs.

Fujifilm Middle East and Africa has officially opened a new office in New Cairo, marking a key step in expanding its footprint in Egypt and the wider region.

Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) has completed its largest acquisition to date, securing a top-selling anti-diabetic product used to treat type 2 diabetes.

Egypt has joined a new $1.5 billion primary health financing platform launched by the World Health Organization (WHO) and three multilateral development banks: the African Development Bank (AfDB), the European Investment Bank (EIB), and the Islamic Development Bank (IDB)

Minister of Health and Population Khaled Abdel Ghaffar announced that E. coli bacteria is the cause of recent illnesses in Aswan, leading to widespread symptoms of intestinal flu among residents.

The ongoing drug shortage crisis in Egypt will be fully resolved within two months.

Egypt will invest EGP 90 billion to build four medical cities across Greater Cairo.

The Egyptian Drug Authority (EDA) has successfully resolved 75% of the ongoing medication shortage.

Prime Minister Mostafa Madbouly met with the Head of the Egyptian Drug Authority (EDA) Ali Ghamrawy to review a report on the availability of medicines in the Egyptian market.

President Abdel Fattah El-Sisi has instructed the government to extend health insurance coverage to 8.5 million beneficiaries of the Takaful and Karama program, as well as irregular workers in the construction and building sectors.